2021
DOI: 10.1017/s0029665121002330
|View full text |Cite
|
Sign up to set email alerts
|

Effect of selenium supplementation on biomarkers of bone turnover

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…The plasma selenium level was within the optimal level during the follow-up period. The levels of bone turnover markers, measured at 6 months, showed a significant linear decrease in the level of procollagen type 1 N-terminal propeptide (P1NP), although this effect was not apparent at 5 years; no significant effect of selenium supplementation on any other bone formation markers was observed [216]. As P1NP is a marker of osteoblast function [217], the decrease in PINP level indicated a reduction in bone formation.…”
Section: Randomized Clinical Trial Of Selenium Intake: Intervention S...mentioning
confidence: 99%
See 1 more Smart Citation
“…The plasma selenium level was within the optimal level during the follow-up period. The levels of bone turnover markers, measured at 6 months, showed a significant linear decrease in the level of procollagen type 1 N-terminal propeptide (P1NP), although this effect was not apparent at 5 years; no significant effect of selenium supplementation on any other bone formation markers was observed [216]. As P1NP is a marker of osteoblast function [217], the decrease in PINP level indicated a reduction in bone formation.…”
Section: Randomized Clinical Trial Of Selenium Intake: Intervention S...mentioning
confidence: 99%
“…Second, the study population included only postmenopausal women, suggesting that further studies investigating elderly people with selenium deficiency are required [215]. A population with relatively low selenium level was investigated in a single-center, randomized, double-blinded, placebo-controlled, multi-arm, parallel clinical trial (PRE-CISE) in Denmark [216]. The 491 volunteers, aged 60-74 years, were randomly and equally assigned to treatment groups administered 100, 200, or 300 µg selenium per day via selenium-enriched yeast for 5 years (from randomization in 1998-1999) and were followed up for further 10 years.…”
Section: Randomized Clinical Trial Of Selenium Intake: Intervention S...mentioning
confidence: 99%
“…No significant effect of selenium supplementation on other bone formation markers was observed. Hence, confirmation of a significant effect of selenium on bone health requires further randomized clinical studies [ 55 ].…”
Section: Introductionmentioning
confidence: 99%